MARKET

NPCE

NPCE

Neuropace Inc
NASDAQ
7.56
-4.46
-37.10%
After Hours: 7.20 -0.36 -4.76% 19:59 11/13 EST
OPEN
6.25
PREV CLOSE
12.02
HIGH
7.71
LOW
5.46
VOLUME
6.11M
TURNOVER
--
52 WEEK HIGH
19.60
52 WEEK LOW
5.46
MARKET CAP
259.49M
P/E (TTM)
-13.3239
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 16h ago
NeuroPace Falls on Lowered Full-Year Guidance Amid Account Issues
Dow Jones · 16h ago
NeuroPace Price Target Cut to $9.00/Share From $20.00 by JP Morgan
Dow Jones · 18h ago
NeuroPace Cut to Neutral From Overweight by JP Morgan
Dow Jones · 18h ago
Leerink downgrades NeuroPace amid commercial setbacks, cuts to growth outlook
TipRanks · 18h ago
NeuroPace Is Maintained at Overweight by Keybanc
Dow Jones · 19h ago
NeuroPace Price Target Cut to $14.00/Share From $18.00 by Keybanc
Dow Jones · 19h ago
NeuroPace price target lowered to $13 from $20 at Lake Street
TipRanks · 19h ago
More
About NPCE
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.

Webull offers Neuropace Inc stock information, including NASDAQ: NPCE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NPCE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NPCE stock methods without spending real money on the virtual paper trading platform.